Abstract Body

Background: Although the HIV care and treatment cascade has typically been portrayed as a linear process starting from HIV testing and counseling to treatment and retention, patients may actually be dropping out of care and re-entering at a later time. We sought to characterize this “side door” phenomenon in a large public health program in Zambia among adults who initiated antiretroviral therapy (ART).

Methodology: Our analysis cohort comprised treatment-naive, HIV-infected adults (≥15 years) initiating ART in 18 Lusaka sites Jan. 2002 – Feb. 2008, including follow-up for their first 3 years on ART. Individuals were divided into 3 groups based on outcomes at 3 years post-ART initiation: 1) remaining on treatment, 2) >60 days late for a scheduled visit but not returning, and 3) >60 days late for a scheduled visit but “re-presenting” into care. Baseline characteristics for the 3 groups were compared and frequency of re-presentation was enumerated. A multivariable logistic model was constructed among those lost to follow-up (LTFU), with a dependent variable of re-presentation/ continued loss and covariates including baseline characteristics.

Results: 48,126 patients were included, median age 34 years (IQR 29,41), 61% women, and median initiation CD4: 132 (IQR 66,205). Among those >60 days late for a scheduled visit (n=28,417), 65.4% never returned, 27.8% had 1 re-presentation episode, 5.3% had 2 re-presentation episodes, and 1.3% had 3 representation episodes. Average period of loss before first re-presentation was 105 days (SD 161), and median 35 days (IQR 10,124). Re-presenting patients were less likely to have CD4<200 cells/mm3, WHO stage 3/4, and anemia (Hemoglobin (Hb) <8 g/dL) at baseline ART initiation (Table). Among those meeting the days-late threshold for LTFU, predictors for re-presentation in a multivariable logistic regression model included lower baseline WHO stage (OR 0.82; 95% CI 0.77-0.88 for WHO Stage 3/4), and higher CD4 cell count (OR 0.92; 95% CI 0.85-0.99 for CD4 <200 cells/ mm3), higher BMI (OR 0.61; 95% CI 0.55-0.68 for <16), and higher Hb (OR 0.77; 95% CI 0.70-0.85 for Hb <8g/dL).

Conclusions: Representation after initial loss to follow-up is common in an urban HIV treatment cohort in Zambia and is more likely in healthier individuals. This is one of the first empiric characterizations of this important phenomenon in ongoing HIV care and treatment efforts, and one that should be considered in the design of future interventions for program retention and monitoring.